Accession SAMC3437746
Accession in Other Database GSA-Human: HRS1186065
Sample name A549-pLKO.1
Title pLKO.1
Sample type Human sample
Organism Homo sapiens
Description Stable cell line
Attributes
Isolate not collected
Age
Biomaterial provider Yu'lab
Sex male
Tissue A-549 cell
Disease
Cell line
Cell subtype
Cell type
Culture collection
Development stage
Disease stage
Ethnicity
Health State
Karyotype
Phenotype
Population
Race
Type
Treatment
Collection date 2021-09-01
Custom attributes
Release date 2024-03-13
BioProject Accession PRJCA024161
Submitter xian  zhao  (jianxiu.yu@gmail.com)
Organization Shanghai Jiao Tong University School of Medicine
Submission date 2024-03-14

Sample Data

Resource name Description
GSA-Human (1) -
HRA006869  (Open Access) N4-acetylcytidine (ac4C) modifcation mainly occurs on tRNA, rRNA, and mRNA, playing an important role in the expression of genetic information. However, it is still unclear whether microRNAs have undergone ac4C modifcation and their potential physiological and pathological functions. In this study, we identifed that NAT10/THUMPD1 acetylates pri-miRNAs with ac4C modifcation.Knockdown of NAT10 suppresses and augments the expression levels of mature miRNAs and pri-miRNAs, respectively. Molecular mechanism studies found that pri-miRNA ac4C promotes the processing of pri-miRNA into precursor miRNA (pre-miRNA) by enhancing the interaction of pri-miRNA and DGCR8, thereby increasing the biogenesis of mature miRNA. Knockdown of NAT10 attenuates the oncogenic characters of lung cancer cells by regulating miRNA production in cancers. Moreover, NAT10 is highly expressed in various clinical cancers and negatively correlated with poor prognosis.
Related samples
Samples (3)